Janney Montgomery Scott’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,429
Closed -$83K 2655
2023
Q1
$83K Buy
+11,429
New +$102K ﹤0.01% 2388
2022
Q4
Sell
-21,373
Closed -$262K 2589
2022
Q3
$262K Buy
21,373
+238
+1% +$3.71K ﹤0.01% 2104
2022
Q2
$263K Sell
21,135
-8,792
-29% -$118K ﹤0.01% 1992
2022
Q1
$569K Buy
29,927
+8,893
+42% +$165K ﹤0.01% 1549
2021
Q4
$558K Sell
21,034
-7,064
-25% -$243K ﹤0.01% 1649
2021
Q3
$1.15M Buy
28,098
+17,962
+177% +$984K ﹤0.01% 1213
2021
Q2
$574K Buy
10,136
+3,910
+63% +$144K ﹤0.01% 1554
2021
Q1
$261K Buy
+6,226
New +$355K ﹤0.01% 1928

Other funds holding EDIT

Janney Montgomery Scott's EDIT Position: Q2 2023 in Review

Janney Montgomery Scott sold out of Editas Medicine (EDIT) in Q2 2023, closing a stake of 11,429 shares — an estimated $83K sold.

Janney Montgomery Scott first reported a position in EDIT in Q1 2021 and held it in 8 quarters. The position peaked at $1.15M in Q3 2021. 237 funds tracked by Wall St. Rank hold EDIT as of Q2 2023.

  • Janney Montgomery Scott reported no remaining Editas Medicine position as of Q2 2023 after selling out during the quarter.
  • Janney Montgomery Scott sold 11,429 Editas Medicine shares in Q2 2023, an estimated $83K.
  • Janney Montgomery Scott first reported a position in Editas Medicine in Q1 2021 and held it in 8 quarters.
  • Janney Montgomery Scott's Editas Medicine position peaked at $1.15M in Q3 2021.
  • 237 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2023.

Based on Janney Montgomery Scott's 13F filing for Q2 2023, filed 26 Jul 2023.